Argus
•
Sep 02, 2026
DVA: Lowering target price to $185.00
Summary
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Technical Assessment: Bullish in the Intermediate-Term
Sep 03, 2026
•
HUM, FCX
CI: Raising target price to $311.00
Sep 02, 2026
•
CI
AON: Lowering target price to $359.00
Sep 02, 2026
•
AON
XRAY: What does Argus have to say about XRAY?
Sep 02, 2026
•
XRAY
WAT: Lowering target price to $446.00
Sep 02, 2026
•
WAT
